Cargando…
New treatment possibilities for postcovid hypogonadism and erectile dysfunction.
OBJECTIVES: COVID-19 affects ACE receptors in testis, that decrease male sexual function. Recently, we have seen an increasing number of patients with erectile dysfunction (ED) appearing 3-6 months after COVID-19. The aim of our study was to determine effectiveness of hormone therapy, autologous ste...
Autores principales: | Knigavko, Oleksandr V., Gramatyuk, Svetlana M., Khanzhyn, Vladyslav V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679763/ http://dx.doi.org/10.1016/j.jsxm.2022.08.095 |
Ejemplares similares
-
New treatment possibilities for postcovid hypogonadism and erectile dysfunction
por: Knigavko, Prof. Oleksandr V., et al.
Publicado: (2022) -
Postcovid Syndrome – The New Reality
por: Khoreva, M. A.
Publicado: (2022) -
Changes of sperm parameters in men recovered from coronavirus disease 2019 (covid-19): a comparison between precovid and postcovid period
por: Yildirim, Omer, et al.
Publicado: (2022) -
The triad of erectile dysfunction, hypogonadism and the metabolic syndrome
por: Shabsigh, R, et al.
Publicado: (2008) -
Hypogonadism and erectile dysfunction as harbingers of systemic disease
por: Chiles, Kelly A.
Publicado: (2016)